Set za proizvodnju kapi za oči iz autolognog seruma Croatia - Croat - HALMED (Agencija za lijekove i medicinske proizvode)

set za proizvodnju kapi za oči iz autolognog seruma

biognost d.o.o., zagreb - priprema alikvota kapi za oči iz autolognih krvnih komponenti krvnog seruma, plazme bogate trombocitima (prp), koncentrata tromb

Carmustine medac (previously Carmustine Obvius) Kesatuan Eropah - Croat - EMA (European Medicines Agency)

carmustine medac (previously carmustine obvius)

medac gesellschaft für klinische spezialpräparate mbh - кармустином - hodgkin disease; lymphoma, non-hodgkin - antineoplastična sredstva - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).

Kymriah Kesatuan Eropah - Croat - EMA (European Medicines Agency)

kymriah

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastični agensi - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Yescarta Kesatuan Eropah - Croat - EMA (European Medicines Agency)

yescarta

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastična sredstva - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

RECORMON 2000 i.j./0.3 mL rastvor za injekciju Bosnia dan Herzegovina - Croat - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

recormon 2000 i.j./0.3 ml rastvor za injekciju

roche d.o.o.roche ltd. - epoetin beta - rastvor za injekciju - 2000 i.j./0.3 ml - 0,3 ml rastvora za injekciju sadrži: 2000 i.u. epoetin beta (humani rekombinantni eritropoetin)

RECORMON MD 50000 i.j./1 viala prašak i rastvarač za rastvor za injekciju Bosnia dan Herzegovina - Croat - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

recormon md 50000 i.j./1 viala prašak i rastvarač za rastvor za injekciju

roche d.o.o.roche ltd. - epoetin beta - prašak i rastvarač za rastvor za injekciju - 50000 i.j./1 viala - 1 bočica sa praškom za rastvor za injekciju sadrži: 50000 i.u. epoetin beta (humani rekombinantni eritropoetin)

RECORMON 2000 i.j./0.3 mL rastvor za injekciju Bosnia dan Herzegovina - Croat - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

recormon 2000 i.j./0.3 ml rastvor za injekciju

roche d.o.o.roche ltd. - epoetin beta - rastvor za injekciju - 2000 i.j./0.3 ml - 0,3 ml rastvora za injekciju sadrži: 2000 i.u. epoetin beta (humani rekombinantni eritropoetin)

Abecma Kesatuan Eropah - Croat - EMA (European Medicines Agency)

abecma

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastična sredstva - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Carvykti Kesatuan Eropah - Croat - EMA (European Medicines Agency)

carvykti

janssen-cilag international nv - ciltacabtagene autoleucel - multipli mijelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

EPREX 2000i.j./0.5ml Rastvor za injekciju u napunjenom injekcionom špricu Montenegro - Croat - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

eprex 2000i.j./0.5ml rastvor za injekciju u napunjenom injekcionom špricu

druŠtvo sa ograniČenom odgovornoŠĆu "inpharm co" podgorica - epoetin alfa - rastvor za injekciju u napunjenom injekcionom špricu - 2000i.j./0.5ml